ArticleBMC microbiology2026
Diabetes-associated modifications in gut microbiota and tryptophan metabolism: implications for macrophage polarization and wound repair in mice.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDiabetic wound (DW) is a severe complication of diabetes with poor healing, linked to gut microbiota dysbiosis, metabolic imbalance, and macrophage polarization disorder. This study aimed to systematically explore the role of the gut-skin axis in DW.
methodsA type 2 diabetes mellitus (T2DM) mouse model was established via high-fat diet feeding and streptozotocin injection. Wound healing was evaluated by histological and immunofluorescence analyses. Gut microbiota composition (16 S rRNA sequencing), serum non-targeted metabolomics (GC-MS), and targeted tryptophan metabolite detection (UPLC-MS/MS) in cecal contents and wound tissues were also performed. Macrophage polarization and cytokine levels were assessed by immunofluorescence and ELISA, respectively.
resultsT2DM mouse model showed delayed wound healing, reduced collagen deposition, impaired neovascularization, and persistent inflammation. 16 S rRNA sequencing revealed decreased gut α-diversity and significantly lower abundances of Lactobacillus johnsonii, Lactobacillus reuteri, and Lactobacillus sp. KC38 in T2DM mice. These Lactobacillus species were positively correlated with wound healing rate. Metabolomic analyses demonstrated suppressed tryptophan-indole metabolism in T2DM mice: cecal and wound levels of indole-3-propionic acid, indole-lactic acid, and other indole metabolites were reduced, accompanied by downregulated aromatic amino acid transaminase and phenyllactate dehydrogenase expression. T2DM mice also exhibited M1 macrophage persistence (elevated CD68 in wound and elevated IL-6, TNF-α, iNOS in serum) and M2 macrophage deficiency (reduced CD206 in wound and decreased IL-10, TGF-β, Arg-1 in serum), with impaired myofibroblast activity (α-SMA) and angiogenesis (CD31). Wound tryptophan-indole metabolites were positively correlated with healing-promoting indices and negatively correlated with pro-inflammatory markers.
conclusionsThe reduction in gut Lactobacillus abundance induced by T2DM is associated with disrupted tryptophan-indole metabolism, which may impair macrophage polarization and wound healing. This study provides a systematic basis for microbiota-targeted therapies for diabetic wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.